Late cutaneous effects of a local potent steroid during adjuvant radiotherapy for breast cancer

Hymes, 2006, Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006, J Am Acad Dermatol, 54, 28, 10.1016/j.jaad.2005.08.054 Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y Dorr, 2001, Consequential late effects in normal tissues, Radiother Oncol, 61, 223, 10.1016/S0167-8140(01)00429-7 Porock, 1999, Management of radiation skin reactions: literature review and clinical application, Plast Surg Nurs, 19, 223 Bray, 2016, Acute and chronic cutaneous reactions to ionizing radiation therapy, Dermatology and therapy, 6, 185, 10.1007/s13555-016-0120-y Lilla, 2007, Predictive factors for late normal tissue complications following radiotherapy for breast cancer, Breast Cancer Res Treat, 106, 143, 10.1007/s10549-006-9480-9 Tucker, 1992, Evidence for individual differences in the radiosensitivity of human skin, Eur J Cancer, 28A, 1783, 10.1016/0959-8049(92)90004-L Bentzen, 1991, Relationship between early and late normal-tissue injury after postmastectomy radiotherapy, Radiother Oncol, 20, 159, 10.1016/0167-8140(91)90092-U Bostrom, 2001, Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study, Radiother Oncol, 59, 257, 10.1016/S0167-8140(01)00327-9 Schmuth, 2002, Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study, Br J Dermatol, 146, 983, 10.1046/j.1365-2133.2002.04751.x Miller, 2011, Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4, Int J Radiat Oncol Biol Phys, 79, 1460, 10.1016/j.ijrobp.2010.01.031 Ulff, 2016, Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: a randomized double blinded study, Radiother Oncol Kolbe, 2001, Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin, Skin Res Technol, 7, 73, 10.1034/j.1600-0846.2001.70203.x Ulff, 2013, A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams, Radiother Oncol, 108, 287, 10.1016/j.radonc.2013.05.033 Swedish Breast Cancer Group. Nationel guidelines for breast cancer; 2011. Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C Yoshida, 2011, Spectrophotometer and ultrasound evaluation of late toxicity following breast-cancer radiotherapy, Med Phys, 38, 5747, 10.1118/1.3633942 Huang, 2007, Reliability of measurement of skin ultrasonic properties in vivo: a potential technique for assessing irradiated skin, Skin Res Technol, 13, 55, 10.1111/j.1600-0846.2006.00191.x Olsen, 1995, High-frequency ultrasound characterization of normal skin. Skin thickness and echographic density of 22 anatomical sites, Skin Res Technol, 1, 74, 10.1111/j.1600-0846.1995.tb00021.x Distante F BE. Hydration. In Bioengineering of the skin: methods and instrumentation Boca Raton-New York-London-Tokyo: CRC Press; 1995. Serup, 2006 Lehmann, 1983, Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy, J Invest Dermatol, 81, 169, 10.1111/1523-1747.ep12543603 Kumar, 2010, Management of skin toxicity during radiation therapy: a review of the evidence, J Med Imaging Radiat Oncol, 54, 264, 10.1111/j.1754-9485.2010.02170.x Turesson, 1989, The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships, Radiother Oncol, 15, 217, 10.1016/0167-8140(89)90089-3 Bentzen, 1989, Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study, Radiother Oncol, 15, 267, 10.1016/0167-8140(89)90095-9